Skip to main content
SpringerLink
Log in

Co-expression of XIAP and CIAP1 Play Synergistic Effect on Patient’s Prognosis in Head and Neck Cancer

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

To explore the influence of chemotherapy on prognosis of Head and Neck Squamous Cell Carcinoma (HNSCC) and the relationship between XIAP and CIAP1 co-expression and the prognosis in HNSCC. 129 patients were recruited in our study, they were divided into two groups, neoadjuvant group (n = 60) and non-neoadjuvant group (n = 69). Expression level of XIAP and CIAP1 were examed in neoadjuvant group, and was correlated with clinical outcomes of the patients. The unselected patients were not benefit from neoadjuvant chemotherapy. Moreover, the patients whose tumors co-express high level of XIAP and CIAP1 presented poorer overall and disease-free survival rates than those whose tumors co-express low level of XIAP and CIAP1 (overall survival P < 0.001, disease-free survival P < 0.001). Our results validate that individual chemotherapy is important for HNSCC, and co-expression of XIAP and CIAP1 prompted a worse prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics. CA Cancer J Clin 51(1):15–36

    Article  CAS  PubMed  Google Scholar 

  2. Chen Z, Seimiya H, Naito M, Mashima T, Kizaki A, Dan S, Imaizumi M, Ichijo H, Miyazono K, Tsuruo T (1999) ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 18(1):173–180

    Article  CAS  PubMed  Google Scholar 

  3. Mase H, Sasaki A, Alcalde RE et al (2000) Regulation of apoptasis reduction in the cisplatin-resistant cell line by Bcl-2 and CPP32. Chemotherapy 46:69–76

    Article  Google Scholar 

  4. Nakano Y, Bilim V, Yuuki K, Muto A, Kato T, Nagaoka A, Tomita Y (2009) Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene down regulation. Prostate Cancer Prostatic Dis 12(1):34–40

    Article  CAS  PubMed  Google Scholar 

  5. McManus DC, Lefebvre CA, Cherton-Horvat G, St-Jean M, Kandimalla ER, Agrawal S, Morris SJ, Durkin JP, LaCasse EC (2004) Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 23:8105–8117

    Article  CAS  PubMed  Google Scholar 

  6. Tamm I, Trepel M, Cardo-Vila M et al (2003) Peptides targeting caspase inhibitors. J Biol Chem 278:14401–14405

    Article  CAS  PubMed  Google Scholar 

  7. Ma J-j, Chen B-l, Xin X-y (2009) XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol 146:222–226

    Article  CAS  PubMed  Google Scholar 

  8. LaCasse EC, Mahoney DJ, Cheung HH et al (2008) IAP-targeted therapies for cancer. Oncogene 27:6252–6275

    Article  CAS  PubMed  Google Scholar 

  9. Reed JC (2001) The survivin saga goes in vivo. J Clin Invest 108:965–969

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Morizane Y, Honda R, Fukami K, Yasuda H (2005) X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J Biochem (Tokyo) 137:125–132

    Article  CAS  Google Scholar 

  11. Scott FL, Denault JB, Riedl SJ, Shin H, Renatus M, Salvesen GS (2005) XIAP inhibits caspase-3 and-7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J 24:645–655

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Suzuki Y, Nakabayashi Y, Takahashi R (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci U S A 98:8662–8667

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Holcik M, Gibson H, Korneluk RG (2001) XIAP: apoptotic brake and pro-mising therapeutic target. Apoptosis 6:253–261

    Article  CAS  PubMed  Google Scholar 

  14. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:3247–3259

    Article  PubMed  Google Scholar 

  15. Hu YP, Cherton-Horvat G, Dragowska V et al (2003) Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 9:2826–2836

    CAS  PubMed  Google Scholar 

  16. Amantana A, London CA, Iversen PL, Devi GR (2004) X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 3(6):699–707

    CAS  PubMed  Google Scholar 

  17. Tirrò E, Consoli ML, Massimino M, Manzella L, Frasca F, Sciacca L, Vicari L, Stassi G, Messina L, Messina A, Vigneri P (2006) Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells. Cancer Res 66(8):4263–4272

    Article  PubMed  Google Scholar 

  18. Yang XH, Feng ZE, Yan M, Hanada S, Zuo H, Yang CZ, Han ZG, Guo W, Chen WT, Zhang P (2012) XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer. PLoS One 7(3):e31601

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S et al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327–333

    Article  CAS  PubMed  Google Scholar 

  20. Liston P, Young SS, Mackenzie AE et al (2004) Life and death decisions: the role of the IAPs in modulating programmed cell death. Apoptosis 2:423–441

    Article  Google Scholar 

  21. Li Y, Jian Z, Xia K, Li X, Lv X, Pei H, Chen Z, Li J (2006) XIAP is related to the chemoresistance and inhibited its expression by RNA interferenc sensitize pancreatic carcinoma cells to chemotherapeutics. Pancreas 32:288–296

    Article  PubMed  Google Scholar 

  22. Holcik M, Yeh C, Korneluk RG, Chow T (2000) Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 19:4174–4177

    Article  CAS  PubMed  Google Scholar 

  23. Guoan X, Xiaomin W, Hanning W, Kaiyun C, Hao L (2009) X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis. J Surg Oncol 100:708–712

    Article  CAS  Google Scholar 

  24. Mizutani Y, Nakanishi H, Li YN, Matsubara H, Yamamoto K, Sato N, Shiraishi T, Nakamura T, Mikami K, Okihara K, Takaha N, Ukimura O, Kawauchi A, Nonomura N, Bonavida B, Miki T (2007) Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Int J Oncol 30(4):919–925

    CAS  PubMed  Google Scholar 

  25. Yang YF, Du H, Huang P et al (2008) XIAP expression and its predictive significance of prognosis in stage IIB osteosarcomas. Chin-Ger J Clin Oncol 7:416–419

    Article  CAS  Google Scholar 

  26. Tanimoto T, Tsuda H, Imazeki N, Ohno Y, Imoto I, Inazawa J, Matsubara O (2005) Nuclear expression of cIAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas. Cancer Lett 224(1):141–151

    Article  CAS  PubMed  Google Scholar 

  27. Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M, Vanderhyden B, Faught W, Fung MFK, Senterman M, Korneluk RG, Tsang BK (2001) Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology 142:370–380

    Article  CAS  PubMed  Google Scholar 

  28. Matsumiya T, Imaizumi T, Yoshida H, Kimura H, Satoh K (2001) Cisplatin inhibits the expression of XIAP in an oral carcinoma cell line. Oral Oncol 37:296–300

    Article  CAS  PubMed  Google Scholar 

  29. Dynek JN, Vucic D (2013) Antagonists of IAP proteins as cancer therapeutics. Cancer Lett 332(2):206–214

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank professor Jinwei zhang for his help in literature analysis and paper writing.

Author information

Author notes

  1. Xi-Hu Yang and Liu Liu contributed equally to this work.

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, 210000, Jiangsu, China

    Xi-Hu Yang & Qin-Gang Hu

  2. Department of Oral and Maxillofacial Surgery, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China

    Liu Liu & Yong-Jie Hu

  3. Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, 02125, USA

    Ping Zhang

Authors
  1. Xi-Hu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yong-Jie Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ping Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qin-Gang Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceived and designed the experiment: XHY LL PZ. Performed the experiments: XHY YJH. Analyzed the data: XHY PZ. Contributed reagents/materials/Analysis tools: PZ QGH. Wrote the paper XHY LL.

Corresponding authors

Correspondence to Ping Zhang or Qin-Gang Hu.

Ethics declarations

Competing Interests

The authors have declared that no competing interests exist.

Grant Support

This study was supported by Jiangsu Province’s Key Provincial Youth Talents Program (Grant No.QNRC2016841); Nanjing Municipal Key Medical Laboratory Constructional Project Funding (Since 2012); Center of Nanjing Clinical Medicine Tumor (Since 2014).

Conflict of Interest

All authors have approved that there are no potential conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, XH., Liu, L., Hu, YJ. et al. Co-expression of XIAP and CIAP1 Play Synergistic Effect on Patient’s Prognosis in Head and Neck Cancer. Pathol. Oncol. Res. 25, 1111–1116 (2019). https://doi.org/10.1007/s12253-018-0533-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-018-0533-2

Keywords

Search

Navigation